Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Neurol. 2007 Feb;64(2):217-22.

Two novel epilepsy-linked mutations leading to a loss of function of LGI1.

Author information

1
INSERM UMR 679, Neurologie and Thérapeutique Expérimentale, Université Pierre et Marie Curie-Paris 6, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, 47 boulevard de l'hôpital, 75013 Paris, France.

Abstract

BACKGROUND:

Mutations in the leucine-rich, glioma-inactivated 1 (LGI1) gene have been implicated in autosomal dominant lateral temporal epilepsy.

OBJECTIVE:

To describe the clinical and genetic findings in 2 families with autosomal dominant lateral temporal epilepsy and the functional consequences of 2 novel mutations in LGI1.

DESIGN:

Clinical, genetic, and functional investigations.

SETTING:

University hospital. Patients Two French families with autosomal dominant lateral temporal epilepsy. Main Outcome Measure Mutation analysis.

RESULTS:

Two novel disease-linked mutations, p.Leu232Pro and c.431 + 1G>A, were identified in LGI1. We demonstrated that the c.431 + 1G>A mutation causes the deletion of exons 3 and 4 of the LGI1 transcript and showed that the p.Leu232Pro mutation dramatically decreases secretion of the mutant protein by mammalian cells.

CONCLUSION:

Our data indicate that LGI1 is a secreted protein and suggest that LGI1-related epilepsy results from a loss of function.

PMID:
17296837
DOI:
10.1001/archneur.64.2.217
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center